BASECARE-B (02170) Plans to Implement H-Share Full Circulation Scheme
Stock News
Yesterday
BASECARE-B (02170) announced that the board of directors has reviewed and approved a proposal to implement an H-share full circulation scheme. This involves converting approximately 191 million of the company's non-listed shares into H-shares. Subject to obtaining all necessary approvals and/or filings, including the filing notice from the China Securities Regulatory Commission and approval from The Stock Exchange of Hong Kong Limited, and compliance with all applicable laws, regulations, and rules, these non-listed shares will be converted into H-shares. The company will then apply for approval for these H-shares to be listed and traded on the Main Board of The Stock Exchange of Hong Kong Limited.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.